Midatech Pharma to acquire Bioasis Technologies Inc. :

Midatech Pharma to acquire Bioasis Technologies Inc.

Related Keywords

Province Of British Columbia , British Columbia , Canada , United States , United Kingdom , London , City Of , British , Canadian , Bioasis Securityholders , Mario Saltarelli , Deborah Rathjen , Midatech Pharma , Company Enlarged Share Capital , Venture Investment , Directors Of The Company , Nasdaq , Prospectus Department , Company To Biodexa Pharmaceuticals , Bioasis Technologies Inc , Placement The Company , Biodexa Pharmaceuticals , Neuramedy Co , London Stock Exchange , Company The Loan Amount , Exchange Ratio , Company Existing Ordinary , Company Ordinary , Ladenburg Thalmann Co , Ab Hk Company , Johnson , Prothena Corporation , Bioasis Technologies , Epidermal Growth Factor , Chiesi Farmaceutici Spa , Janssen Pharmaceutica , Enlarged Group , Registered Direct Offering , Private Placement , Stephen Stamp , Ordinary Shares , Ordinary Share , Existing Shareholders , General Meeting , Sijmen De Vries , Placing Price , Bioasis Shareholders , Acquisition Resolutions , Lind Debt , Pre Funded Warrants , Pre Funded Warrant , Placing Warrants , Takeover Code , Securities Purchase Agreement , Subsequent Financing , Ladenburg Thalmann , Bioasis Convertible Security Agreement , Bioasis Investment Banking , Bioasis Promissory Note , Loan Amount , Bioasis Maturity Date , Existing Ordinary Shares , Enlarged Share Capital , Depositary Bank , Company Limited , Transaction Shares , Warrant Shares , New Warrants ,